Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Lung macrophages play a pivotal role in diseases like idiopathic pulmonary fibrosis. Two types of macrophages—the white blood ...

Results come after positive results from a trial among people with idiopathic pulmomary disease.

Panelists discuss how emerging, better-tolerated oral therapies for idiopathic pulmonary fibrosis (IPF) and progressive ...

Send comments and news tips to [email protected]. Cite this: Edited by Shreyasi Asthana. Nerandomilast May Slow Down Progressive Pulmonary Fibrosis - Medscape - June 26, 2025.

Both are capable of affecting the lungs and sharing similar symptoms such as cough and shortness of breath but knowing their different causes contagious nature and treatment methods is crucial Read ...

Panelists discuss recent trial data demonstrating that a novel agent not only slows lung function decline but also delays ...

Chinese scientists have developed a novel nanotherapy known as biomimetic extracellular vesicle spherical nucleic acids ...

The secrets of idiopathic pulmonary fibrosis (IPF) are written in its very name. Idiopathic refers to a disease of unknown ...

Currently available treatments for IPF are limited to only two approved drugs that come with significant side-effects, ...

Pulmonary rehabilitation is initiated and completed by a greater proportion of patients with IPF vs COPD or other chronic respiratory disorders.